-
This is how rhe future of biofilm diagnosis looks like .... more research needed!!! C. Williams at
#ECCMID2018 pic.twitter.com/gJY68tuxNP
-
Courtney presenting on comprehensive statewide genomic surveillance for CPE in Australia at
#ECCMID2018. Great work! pic.twitter.com/dWfb4KPagq
-
Save your money
Fosfomycin daily dosing had no impact over every other day dosing in urine concentration per @TheIDApprentice#ECCMID2018 pic.twitter.com/dHUdc4bKqA
-
-
#ECCMID2018 Hollian explaining our 6h straight from sample workflow using@nanopore MinIONpic.twitter.com/DhF7aQrnB0
-
When is beta lactam dose optimisation valuable? A masterclass in beta lactam TDM from
@jasonroberts_pk to round out#ECCMID2018@ESCMIDpic.twitter.com/fVlqmh0Kol
-
#ECCMID2018 Hot topics on methods for clinical research in infectious diseases.
Always learning from Dr Belen Gutierrez-Gutierrez pic.twitter.com/fBrLpK5Lb0
-
Recipe for a superbug according to James Johnson at
#ECCMID2018 pic.twitter.com/WQ3Bd3JGrQ
-
-
“Penicillin allergy” is a devastating epidemic. Get tested!
#ECCMID2018#ESCMIDpic.twitter.com/VENofuK22V
-
What drives resistance in biofilms:
+ charge,
O2 and nutrients for metabolism,
efflux pump, selection for resistant colonies along exterior surfaces of the film. #ECCMID2018 pic.twitter.com/qLVL2gNG9e
-
My little bug fighters with the great educational aids from
@biomerieux at#ECCMID2018@ESCMID@ECCMIDpic.twitter.com/PlUr18Bh5m
-
Important follow up. Just a sample of the isolates, but in my opinion might help explain findings. Note that MIC distribution to PT.
#ECCMID2018 pic.twitter.com/ug88qyNJ6j
Prikaži ovu nit -
Me and
@jankluytmans are chairing a session on E. coli tomorrow morning - can't promise any dragons but we've got 4 great speakers#ECCMID2018 pic.twitter.com/ccyb2F5YF9
-
#ECCMID2018 Hollian showing an example of how we can diagnose#amr straight from clinical samples within 6h using@nanopore MinION sequencingpic.twitter.com/Ylr1VH7BqJ
-
Great approach to overcome with barriers on
#AMS implementation: technical solutions and adaptative challanges .#ECCMID2018@joserrapapic.twitter.com/NaJn7kMm9N
-
Standard beta-lactam doses fail to achieve PK/PD targets in critically ill patients of all ages, with children particularly at risk: results from the ABDose study Presenting work from St George's ICU at
#ECCMID2018 in this afternoon's oral eposter session pic.twitter.com/XH2ylZRZim
-
Repping the
@LonaMody research group at#ECCMID2018 is@umichmedicine Hospital Epidemiologist, Dr. Washer. 1. Patient
are often colonized w MDROs and correlate w MDRO colonization of high touch surfaces
2. Targeted
hygiene efforts for patients could
MDRO burdenpic.twitter.com/gm1MDZYh0Z
-
Interested in fight against antimicrobial resistance from research, politics and scientific societies perspectives? Join us at
@ESCMID Open Forum at 12.45 today in ePoster Arena 3#ECCMID2018 pic.twitter.com/4fyfH0IoN4
-
...and after the dark side of science with predatory journals, let's move to high level research that improve the care of our patients
#ECCMID2018. Preparing the future@ESCMID guideline on infections due to MDR gram-negative bacteria.pic.twitter.com/EhXPaIykMV
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.